Literature DB >> 3103909

Killing and mutation of human lymphoblast cells by aflatoxin B1: evidence for an inducible repair response.

D A Kaden, K M Call, P M Leong, E A Komives, W G Thilly.   

Abstract

Diploid human lymphoblast cells exhibit apparent saturation of mutation induced by exposure to aflatoxin B1, despite a linear increase in the amount and proportion of the aflatoxin-DNA adducts formed. The saturation is neither a cell cycle phenomenon nor a result of a genetically heterozygous population. Examination of the biphasic nature of aflatoxin-DNA adduct loss in vivo shows initial, rapid removal of all adduct species, followed by a slow loss of the aflatoxin-N7-guanine adduct alone. We hypothesize that these data reveal two modes of adduct loss in these cells. The first is an inducible, error-free system that is short-lived, turning off as adduct levels fall below the induction threshold of some 1000 total adducts/cell. The second loss is slower and results from spontaneous depurination of remaining aflatoxin-N7-guanines. Our data are in agreement with the possibility that apurinic sites thus generated are responsible for the mutation observed. A major paradox arises from the fact that aflatoxin-related premutagenic depurinations are estimated to be only 10% of the number of spontaneous depurinations estimated by others to occur in human cells in a 1-h period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103909

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1.

Authors:  Kyle L Brown; James Z Deng; Rajkumar S Iyer; Lalitha G Iyer; Markus W Voehler; Michael P Stone; Constance M Harris; Thomas M Harris
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

2.  Cytotoxicity of aflatoxin on red blood corpuscles.

Authors:  R J Verma; P J Raval
Journal:  Bull Environ Contam Toxicol       Date:  1991-09       Impact factor: 2.151

3.  A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site.

Authors:  E A Bailey; R S Iyer; T M Harris; J M Essigmann
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

4.  Mutational properties of the primary aflatoxin B1-DNA adduct.

Authors:  E A Bailey; R S Iyer; M P Stone; T M Harris; J M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli.

Authors:  P L Foster; J D Groopman; E Eisenstadt
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

6.  Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.

Authors:  Sridevi Bodreddigari; Laundette Knight Jones; Patricia A Egner; John D Groopman; Carrie Hayes Sutter; Bill D Roebuck; F Peter Guengerich; Thomas W Kensler; Thomas R Sutter
Journal:  Chem Res Toxicol       Date:  2008-04-15       Impact factor: 3.739

7.  Chemical Biology of N5-Substituted Formamidopyrimidine DNA Adducts.

Authors:  Suresh S Pujari; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2016-12-13       Impact factor: 3.739

8.  Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.

Authors:  Natalie M Johnson; Patricia A Egner; Victoria K Baxter; Michael B Sporn; Ryan S Wible; Thomas R Sutter; John D Groopman; Thomas W Kensler; Bill D Roebuck
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-24

9.  Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Authors:  Bill D Roebuck; Denise N Johnson; Carrie Hayes Sutter; Patricia A Egner; Peter F Scholl; Marlin D Friesen; Karen J Baumgartner; Nicholas M Ware; Sridevi Bodreddigari; John D Groopman; Thomas W Kensler; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2009-01-23       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.